Home / Daptomycin / Canada
CA ATC J01XX09 · updated 2 Nov 2026
Daptomycin shortage in Canada
Is there a Daptomycin shortage in Canada?
Yes. As of 2 Nov 2026, 3 Daptomycin products are reported short in Canada, the first since 23 Oct 2023. The company estimate for the return is 27 Nov 2026. Main reason: manufacturing problem.
Also short in United States, Italy, Spain, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | DAPTOMYCIN FOR INJECTION (1) | ACCORD HEALTHCARE INC | 23 Oct 2023 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | DAPTOMYCIN FOR INJECTION (LYVI) | SANDOZ CANADA INCORPORATED | 13 Oct 2026 | 27 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | CUBICIN RF (10 mL Vial) discontinuation | CUBIST PHARMACEUTICALS LLC | not given | not given | Not stated |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.